New heartburn drug enters final testing phase
NCT ID NCT07160790
Summary
This study is testing whether a new drug called JP-1366 can safely reduce heartburn and acid reflux symptoms in people with non-erosive GERD, a condition where they experience symptoms but no visible damage in their esophagus. Researchers will measure how many days participants go without heartburn. The trial needs 321 adults who regularly experience both heartburn and acid regurgitation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.